DK573788D0 - Quinolinderivater eller farmaceutiske acceptable estere eller salte deraf, deres fremstilling og anvendelse - Google Patents
Quinolinderivater eller farmaceutiske acceptable estere eller salte deraf, deres fremstilling og anvendelseInfo
- Publication number
- DK573788D0 DK573788D0 DK573788A DK573788A DK573788D0 DK 573788 D0 DK573788 D0 DK 573788D0 DK 573788 A DK573788 A DK 573788A DK 573788 A DK573788 A DK 573788A DK 573788 D0 DK573788 D0 DK 573788D0
- Authority
- DK
- Denmark
- Prior art keywords
- salts
- preparation
- pharmaceutical acceptable
- acceptable esters
- quinoline derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26244187 | 1987-10-16 | ||
| JP10884088 | 1988-04-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK573788D0 true DK573788D0 (da) | 1988-10-14 |
| DK573788A DK573788A (da) | 1989-04-17 |
Family
ID=26448650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK573788A DK573788A (da) | 1987-10-16 | 1988-10-14 | Quinolinderivater eller farmaceutiske acceptable estere eller salte deraf, deres fremstilling og anvendelse |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5013841A (da) |
| EP (1) | EP0312085B1 (da) |
| KR (1) | KR930006774B1 (da) |
| CN (1) | CN1021967C (da) |
| DE (1) | DE3880953T2 (da) |
| DK (1) | DK573788A (da) |
| ES (1) | ES2054762T3 (da) |
| FI (1) | FI884752A (da) |
| HU (1) | HU204521B (da) |
| IL (1) | IL88003A (da) |
| NO (1) | NO171016C (da) |
| NZ (1) | NZ226574A (da) |
| PH (1) | PH25530A (da) |
| PT (1) | PT88769A (da) |
| RU (2) | RU1780534C (da) |
| YU (3) | YU46647B (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL88003A (en) * | 1987-10-16 | 1992-11-15 | Dainippon Pharmaceutical Co | Quinoline derivatives,their preparation and pharmaceutical compositions containing them |
| US5262417A (en) * | 1988-12-06 | 1993-11-16 | The Upjohn Company | Antibacterial quinolone compounds |
| ATE193890T1 (de) | 1990-04-18 | 2000-06-15 | Procter & Gamble Pharma | Antimikrobielle chinolonyl-lactame |
| DE4019023A1 (de) * | 1990-06-14 | 1991-12-19 | Bayer Ag | Verfahren zur herstellung von chinolincarbonsaeuren |
| TW252107B (da) * | 1993-08-27 | 1995-07-21 | Hokuriku Pharmacetical Co Ltd | |
| CA2467321A1 (en) * | 2004-05-14 | 2005-11-14 | Paul J. Santerre | Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
| FR2916446B1 (fr) * | 2007-05-24 | 2009-08-21 | Biocodex Sa | Nouveau procede de synthese de fluoroquinolones |
| US20210113457A1 (en) | 2018-02-02 | 2021-04-22 | Ripple Therapeutics Corporation | Glass formulations and uses thereof |
| MX2022013665A (es) | 2020-05-01 | 2022-11-30 | Ripple Therapeutics Corp | Composiciones y metodos heterodimeros para el tratamiento de trastornos oculares. |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3142854A1 (de) * | 1981-10-29 | 1983-05-11 | Bayer Ag, 5090 Leverkusen | 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
| DE3248506A1 (de) * | 1982-12-29 | 1984-07-05 | Bayer Ag, 5090 Leverkusen | 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
| AU594983B2 (en) * | 1985-10-29 | 1990-03-22 | Dainippon Pharmaceutical Co. Ltd. | Novel quinoline derivatives and processes for preparation thereof |
| DE3542002A1 (de) * | 1985-11-28 | 1987-06-04 | Bayer Ag | 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
| US4668680A (en) * | 1985-12-12 | 1987-05-26 | Warner-Lambert Company | 5-amino-6,8-difluoroquinolones as antibacterial agents |
| JPS62215572A (ja) * | 1986-03-17 | 1987-09-22 | Kyorin Pharmaceut Co Ltd | キノロンカルボン酸誘導体 |
| EP0242789A3 (en) * | 1986-04-25 | 1990-09-05 | Dainippon Pharmaceutical Co., Ltd. | Novel quinoline derivates and processes for preparation thereof |
| DE3711193A1 (de) * | 1987-04-02 | 1988-10-13 | Bayer Ag | 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate |
| US5563138A (en) * | 1987-04-16 | 1996-10-08 | Otsuka Pharmaceutical Company, Limited | Benzoheterocyclic compounds |
| IL88003A (en) * | 1987-10-16 | 1992-11-15 | Dainippon Pharmaceutical Co | Quinoline derivatives,their preparation and pharmaceutical compositions containing them |
-
1988
- 1988-10-11 IL IL88003A patent/IL88003A/xx unknown
- 1988-10-14 FI FI884752A patent/FI884752A/fi not_active Application Discontinuation
- 1988-10-14 NZ NZ226574A patent/NZ226574A/en unknown
- 1988-10-14 DK DK573788A patent/DK573788A/da not_active Application Discontinuation
- 1988-10-14 ES ES88117113T patent/ES2054762T3/es not_active Expired - Lifetime
- 1988-10-14 EP EP88117113A patent/EP0312085B1/en not_active Expired - Lifetime
- 1988-10-14 DE DE88117113T patent/DE3880953T2/de not_active Expired - Fee Related
- 1988-10-14 PH PH37684A patent/PH25530A/en unknown
- 1988-10-14 NO NO884599A patent/NO171016C/no unknown
- 1988-10-14 YU YU192288A patent/YU46647B/sh unknown
- 1988-10-14 PT PT88769A patent/PT88769A/pt unknown
- 1988-10-14 HU HU885296A patent/HU204521B/hu not_active IP Right Cessation
- 1988-10-15 KR KR1019880013470A patent/KR930006774B1/ko active IP Right Grant
- 1988-10-15 CN CN88108434A patent/CN1021967C/zh not_active Expired - Fee Related
-
1989
- 1989-08-04 US US07/389,900 patent/US5013841A/en not_active Expired - Fee Related
- 1989-10-13 YU YU198989A patent/YU46684B/sh unknown
- 1989-10-13 YU YU199089A patent/YU46703B/sh unknown
- 1989-10-18 RU SU894742183A patent/RU1780534C/ru active
- 1989-10-20 RU SU894742186A patent/RU1830067C/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| KR930006774B1 (ko) | 1993-07-23 |
| YU46647B (sh) | 1994-01-20 |
| AU2375488A (en) | 1989-04-20 |
| RU1830067C (ru) | 1993-07-23 |
| NO884599L (no) | 1989-04-17 |
| DE3880953D1 (de) | 1993-06-17 |
| NO171016B (no) | 1992-10-05 |
| PH25530A (en) | 1991-07-24 |
| FI884752A0 (fi) | 1988-10-14 |
| RU1780534C (ru) | 1992-12-07 |
| YU198989A (en) | 1990-04-30 |
| FI884752A (fi) | 1989-04-17 |
| DK573788A (da) | 1989-04-17 |
| AU619214B2 (en) | 1992-01-23 |
| KR890006620A (ko) | 1989-06-14 |
| HU204521B (en) | 1992-01-28 |
| EP0312085B1 (en) | 1993-05-12 |
| PT88769A (pt) | 1989-07-31 |
| YU199089A (en) | 1990-04-30 |
| HUT49342A (en) | 1989-09-28 |
| NZ226574A (en) | 1991-07-26 |
| CN1033996A (zh) | 1989-07-19 |
| ES2054762T3 (es) | 1994-08-16 |
| IL88003A0 (en) | 1989-06-30 |
| NO884599D0 (no) | 1988-10-14 |
| EP0312085A3 (en) | 1990-05-30 |
| CN1021967C (zh) | 1993-09-01 |
| YU192288A (en) | 1990-04-30 |
| YU46684B (sh) | 1994-04-05 |
| NO171016C (no) | 1993-01-13 |
| US5013841A (en) | 1991-05-07 |
| IL88003A (en) | 1992-11-15 |
| EP0312085A2 (en) | 1989-04-19 |
| YU46703B (sh) | 1994-04-05 |
| DE3880953T2 (de) | 1993-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK208787A (da) | Quinolinderivater og farmaceutisk acceptable estere deraf, deres farmaceutisk acceptable salte samt fremstilling og anvendelse deraf | |
| DK434488A (da) | Heteroarylethere og heteroaromatiske n-oxider eller farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse | |
| NO860141L (no) | Tiazolidindionderivater og fremgangsmaate for deres fremstilling. | |
| DK569087D0 (da) | Quinolin-derivater, deres fremstilling og anvendelse | |
| DK290188D0 (da) | Alkoxysubstituerede dihydrobenzopyran-2-carboxylatderivater og farmaceutiske acceptable salte deraf samt deres anvendelse | |
| NO892745D0 (no) | Aminoalkylaminokarbonylaminodiolaminosyrederivater og fremgangsmaate for deres fremstilling. | |
| DK519189A (da) | Spiro-isoquinolin-pyrrolidin-tetroner eller farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse | |
| DK399789D0 (da) | Annellerede tetrahydropyridineddikesyrederivater, deres fremstilling og anvendelse | |
| NO871526L (no) | Tiolaktam-n-eddiksyrederivater og fremgangsmaate for deres fremstilling. | |
| DK266486A (da) | Quinoloncarboxylsyreestere eller farmaceutisk anvendelige hydratereller syreadditionssalte deraf, deres fremstilling og anvendelse | |
| DK461389D0 (da) | Quinolyloxazol-2-oner og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse | |
| DK29287A (da) | 7-(azabicycloalkyl)-quinoloncarboxylsyre- og -naphthyridonboxylsyrederivater, deres fremstilling og anvendelse | |
| DK573788D0 (da) | Quinolinderivater eller farmaceutiske acceptable estere eller salte deraf, deres fremstilling og anvendelse | |
| DK688888D0 (da) | Substituerede 1,4-dihydro-4-oxoquinolin-3-carboxylsyrer, farmaceutisk acceptable estre eller salte deraf, deres fremstilling og anvendelse | |
| DK543788A (da) | Reninhaemmende dipeptider eller fysiologisk acceptable salte deraf, deres fremstilling og anvendelse | |
| DK157387A (da) | Substiturede 4-amino-3-hydroxysmoersyrederivater ogfysiologisk acceptable salte deraf, deres fremstilling og anvendelse | |
| DK192588D0 (da) | Pyrrolaldehyder eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse | |
| DK501888A (da) | 6-mercaptopurin-derivater, deres fremstilling og anvendelse som laegemidler | |
| DK238089A (da) | Substituerede 3-aminosydnoniminer eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse | |
| DK299983A (da) | Racemiske eller optisk aktive apovincaminsyrederivater eller farmaceutisk aktive syreadditionssalte deraf, deres fremstilling og anvendelse | |
| DK454588D0 (da) | Substituerede thienoimidazolderivater, deres fremstilling, farmaceutiske praeparater deraf og deres anvendelse som mavesyresekretionshaemmende midler | |
| DK404386D0 (da) | Spergualinbeslaegtede forbindelser eller fysiologisk acceptable salte deraf, deres fremstilling og anvendelse | |
| DK291986A (da) | 10alfa-methoxy-6-methylergolinderivater eller fysiologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse | |
| DK120088A (da) | Cephalosporinderivater og fysiologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse | |
| DK559388A (da) | Anthracyclinderivater og farmaceutisk uskadelige syreadditionssalte deraf, deres fremstilling og anvendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |